questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérocycliques avec 4 noyaux ou plus
Ergotamines
Ergotamines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Communicable Disease Control
Diagnostic
5
Migraine
Diagnostic médical
Imagerie par résonance magnétique
Migraine
Critères diagnostiques
Migraine
Antécédents familiaux
Migraine
Symptômes
5
Variabilité des symptômes
Migraine
Prévention
5
Prévention des migraines
Déclencheurs de migraine
Régime alimentaire
Migraine
Exercice physique
Migraine
Thérapies alternatives
Migraine
Traitements
5
Ergotamines
Traitement de la migraine
Effets secondaires
Ergotamines
Efficacité du traitement
Ergotamines
Interactions médicamenteuses
Ergotamines
Voie d'administration
Ergotamines
Complications
5
Accident vasculaire cérébral
Migraine
Migraine chronique
Qualité de vie
Fonction cognitive
Migraine
Gestion des complications
Migraine
Facteurs de risque
5
Facteurs de risque
Migraine
Fluctuations hormonales
Migraine
Habitudes alimentaires
Migraine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ergotamines : Questions médicales les plus fréquentes",
"headline": "Ergotamines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ergotamines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ergotamines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"url": "https://questionsmedicales.fr/mesh/D006576",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"code": {
"@type": "MedicalCode",
"code": "D006576",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromocriptine",
"alternateName": "Bromocriptine",
"url": "https://questionsmedicales.fr/mesh/D001971",
"about": {
"@type": "MedicalCondition",
"name": "Bromocriptine",
"code": {
"@type": "MedicalCode",
"code": "D001971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocornine",
"alternateName": "Dihydroergocornine",
"url": "https://questionsmedicales.fr/mesh/D025441",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocornine",
"code": {
"@type": "MedicalCode",
"code": "D025441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocristine",
"alternateName": "Dihydroergocristine",
"url": "https://questionsmedicales.fr/mesh/D025442",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocristine",
"code": {
"@type": "MedicalCode",
"code": "D025442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "alpha-Dihydroergocryptine",
"alternateName": "Dihydroergocryptine",
"url": "https://questionsmedicales.fr/mesh/D025443",
"about": {
"@type": "MedicalCondition",
"name": "alpha-Dihydroergocryptine",
"code": {
"@type": "MedicalCode",
"code": "D025443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotamine",
"alternateName": "Dihydroergotamine",
"url": "https://questionsmedicales.fr/mesh/D004087",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotoxine",
"alternateName": "Dihydroergotoxine",
"url": "https://questionsmedicales.fr/mesh/D004088",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotoxine",
"code": {
"@type": "MedicalCode",
"code": "D004088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"alternateName": "Ergoloid Mesylates",
"url": "https://questionsmedicales.fr/mesh/D004877",
"about": {
"@type": "MedicalCondition",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"code": {
"@type": "MedicalCode",
"code": "D004877",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ergotamine",
"alternateName": "Ergotamine",
"url": "https://questionsmedicales.fr/mesh/D004878",
"about": {
"@type": "MedicalCondition",
"name": "Ergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004878",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ergotamines",
"alternateName": "Ergotamines",
"code": {
"@type": "MedicalCode",
"code": "D004879",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Manoj B Kudupoje",
"url": "https://questionsmedicales.fr/author/Manoj%20B%20Kudupoje",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Eric S Vanzant",
"url": "https://questionsmedicales.fr/author/Eric%20S%20Vanzant",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Kyle R McLeod",
"url": "https://questionsmedicales.fr/author/Kyle%20R%20McLeod",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Alexandros Yiannikouris",
"url": "https://questionsmedicales.fr/author/Alexandros%20Yiannikouris",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Wiebke Rudolph",
"url": "https://questionsmedicales.fr/author/Wiebke%20Rudolph",
"affiliation": {
"@type": "Organization",
"name": "a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Losses of Life Expectancy and Productivity Associated with COVID-19 Pandemic in Canada: Policy Implication for Future Communicable Disease Control.",
"datePublished": "2023-01-29",
"url": "https://questionsmedicales.fr/article/36767785",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20032419"
}
},
{
"@type": "ScholarlyArticle",
"name": "Opportunistic non-communicable diseases in times of COVID-19.",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36177674",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/apm.13274"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in Japan.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36642212",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijid.2023.01.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Opportunities and Challenges for Regional Coordination of Infectious Disease Control Comment on \"Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks\".",
"datePublished": "2022-12-10",
"url": "https://questionsmedicales.fr/article/37579350",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/ijhpm.2022.7533"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differential Mental Health Impact of COVID-19 Lockdowns on Persons with Non-Communicable Diseases in Trinidad and Tobago.",
"datePublished": "2023-08-08",
"url": "https://questionsmedicales.fr/article/37623129",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20166543"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"item": "https://questionsmedicales.fr/mesh/D006576"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ergotamines",
"item": "https://questionsmedicales.fr/mesh/D004879"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ergotamines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ergotamines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ergotamines",
"description": "Comment diagnostiquer une migraine ?\nQuels tests sont utilisés pour les migraines ?\nLes ergots sont-ils prescrits pour d'autres maux de tête ?\nQuels critères sont utilisés pour le diagnostic ?\nLes antécédents familiaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Communicable+Disease+Control#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ergotamines",
"description": "Quels sont les symptômes d'une migraine ?\nLes migraines provoquent-elles des vomissements ?\nY a-t-il des signes avant-coureurs de migraine ?\nLes migraines peuvent-elles causer des vertiges ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Communicable+Disease+Control#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ergotamines",
"description": "Comment prévenir les migraines ?\nLes changements alimentaires aident-ils à prévenir les migraines ?\nLe stress influence-t-il la fréquence des migraines ?\nLes exercices physiques aident-ils à prévenir les migraines ?\nLes thérapies alternatives sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Communicable+Disease+Control#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ergotamines",
"description": "Comment les ergots soulagent-ils les migraines ?\nQuels sont les effets secondaires des ergots ?\nLes ergots sont-ils efficaces pour tous les patients ?\nPeut-on combiner les ergots avec d'autres médicaments ?\nQuelle est la voie d'administration des ergots ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Communicable+Disease+Control#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ergotamines",
"description": "Quelles sont les complications possibles des migraines ?\nLes migraines peuvent-elles entraîner des AVC ?\nLes migraines chroniques ont-elles des conséquences ?\nLes migraines peuvent-elles causer des problèmes cognitifs ?\nComment gérer les complications des migraines ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Communicable+Disease+Control#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ergotamines",
"description": "Quels sont les facteurs de risque des migraines ?\nL'âge influence-t-il le risque de migraines ?\nLes changements hormonaux affectent-ils les migraines ?\nLe manque de sommeil est-il un facteur de risque ?\nLes habitudes alimentaires influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Communicable+Disease+Control#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une migraine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique des symptômes et des examens neurologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les migraines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM peuvent être utilisés pour exclure d'autres causes."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils prescrits pour d'autres maux de tête ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont principalement prescrits pour les migraines, pas pour d'autres types de céphalées."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, la durée et l'intensité des crises de migraine."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de migraines peuvent augmenter la probabilité de diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une migraine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs pulsatiles, des nausées et une sensibilité à la lumière."
}
},
{
"@type": "Question",
"name": "Les migraines provoquent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements peuvent accompagner les migraines chez certains patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes avant-coureurs de migraine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles visuels ou des picotements peuvent précéder une migraine."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des vertiges ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent des vertiges ou des étourdissements pendant une crise."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les migraines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs connus, maintenir un mode de vie sain et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils à prévenir les migraines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments peuvent déclencher des migraines, leur évitement peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la fréquence des migraines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress est un déclencheur courant des migraines et sa gestion est cruciale."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils à prévenir les migraines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité physique régulière peut réduire la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les thérapies alternatives sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies comme l'acupuncture peuvent aider à réduire la fréquence des migraines."
}
},
{
"@type": "Question",
"name": "Comment les ergots soulagent-ils les migraines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots agissent en constrictant les vaisseaux sanguins et en réduisant l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des ergots ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils efficaces pour tous les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité peut varier et certains patients peuvent ne pas y répondre."
}
},
{
"@type": "Question",
"name": "Peut-on combiner les ergots avec d'autres médicaments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quelle est la voie d'administration des ergots ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots peuvent être administrés par voie orale, nasale ou injectable selon le cas."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des migraines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de l'humeur, des problèmes de sommeil et des AVC."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines avec aura peuvent augmenter le risque d'accident vasculaire cérébral."
}
},
{
"@type": "Question",
"name": "Les migraines chroniques ont-elles des conséquences ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affecter la qualité de vie et entraîner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des problèmes cognitifs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les migraines fréquentes peuvent affecter la cognition."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des migraines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins et psychologues est souvent nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des migraines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le sexe féminin, et le stress."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de migraines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines sont plus fréquentes chez les jeunes adultes et les femmes d'âge moyen."
}
},
{
"@type": "Question",
"name": "Les changements hormonaux affectent-ils les migraines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les fluctuations hormonales, notamment pendant le cycle menstruel, peuvent déclencher des migraines."
}
},
{
"@type": "Question",
"name": "Le manque de sommeil est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le manque de sommeil peut augmenter la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments et boissons peuvent déclencher des migraines chez certaines personnes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States.
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
1 publication dans cette catégorie
Affiliations :
Division 1.7, Organic Trace and Food Analysis, Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. 11, 12489 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Toxicology, Technische Universität Berlin, Gustav-Meyer-Allee 25, 13355 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Division 1.7, Organic Trace and Food Analysis, Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. 11, 12489 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneshwar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Urology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
This research examines whether the Coronavirus disease 2019 (COVID-19) did harm to the population's health through comparing the changes in the life expectancy of Canadians with those of Australians o...
We previously proposed the term 'opportunistic non-communicable diseases (NCDs)' to raise awareness of how NCDs thrive in societies with inadequate healthcare services. However, we did not anticipate ...
To elucidate the impact of the COVID-19 pandemic on the epidemiology of other infectious diseases....
We investigated the epidemiology of 36 communicable diseases during 2015-2021 in Japan and compared the number of cases in each disease between the prepandemic (2015-2019) and intrapandemic (2020-2021...
Of 36 communicable diseases, the number of cases in the 27 diseases (75%) mainly caused by pathogens transmitted by droplet or contact was lower intrapandemic than prepandemic, and the cases of 21 dis...
The COVID-19 pandemic has greatly impacted the epidemiology of communicable diseases, suggesting that countermeasures against COVID-19 and lifestyle changes might be involved in these epidemiological ...
This commentary cites a scoping review by Durrance-Bagale et al (2021) on how regional bodies have approached infectious disease control to determine if those lessons could be applied to assist the As...
Persons with chronic non-communicable diseases (NCDs) were identified as particularly at risk of severe morbidity and mortality during the COVID-19 pandemic. Little is written about the impact of COVI...
AbstractAccurate diagnostics are critical in public health to ensure successful disease tracking, prevention, and control. Many of the same characteristics are desirable for diagnostic procedures in b...
Desirable outcomes for people with non-communicable diseases (NCDs) are achieved when they access routine monitoring and care services. Expectedly, the COVID-19 pandemic severely impacted access to he...
We conducted an exploratory qualitative research guided by the "Three Delays" model to unpack the barriers to healthcare access for people living with NCDs in Ibadan, Nigeria. The "Three Delays" model...
At the level of individual decision-making, delays were related to fear of contracting COVID-19 in the hospital (considered a hotspot of the COVID-19 pandemic). Regarding reaching an appropriate healt...
Pandemic conditions provide unique challenges to people with chronic illnesses. Recognizing the need for continuous access to monitoring and care services under such conditions remains critical. Alter...
Cholera remains a significant public health problem among the vulnerable populations living in many resource-limited settings with poor access to safe and clean water and hygiene practice. Around 2.86...
Medical treatment is considered a cornerstone in non-communicable diseases (NCDs) management, lack of adherence remains the main challenge that may compromise optimal therapeutic outcome achievement....
This study aimed to evaluate treatment adherence levels and associated factors among Lebanese adult patients with non-communicable diseases....
A cross-sectional survey conducted during the COVID-19 lockdown imposed by the Lebanese Government (between September 2020 and January 2021) enrolled 263 adult patients through an anonymous online que...
Of the total sample, 50.2% showed low adherence with a total mean adherence score of 4.41 ± 3.94. The results showed that depression (...
Our study shed light on the factors affecting medication adherence in patients with non-communicable diseases. It showed that depression and peptic ulcer were associated with lower adherence, contrary...
Infectious diseases persistently pose global threats, and it is imperative to accelerate the professionalization of public health workforce. This study aimed to develop and validate the infectious dis...
The initial item pool was generated through a literature review, and categorized into three dimensions (knowledge, practical skills, and leadership) based on the competency iceberg model and public he...
An initial scale with three primary items, 14 secondary items, and 81 tertiary items was generated. Twenty experts participated in the two rounds of the Delphi process. Authority coefficients exceeded...
The IDCCS was established to evaluate the competencies of knowledge, practical skills, leadership, and personal quality for public health professionals in infectious disease control. This scale demons...